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Abstract:
Background 
Individuals with eating disorders (EDs) have a high mortality risk. Few 
population-based studies have estimated mortality risk in EDs other than 
anorexia nervosa. 
Aims 
To investigate all-cause mortality within a population-based cohort of 
individuals who received hospital-based care for any ED (anorexia 
nervosa, bulimia nervosa or ED not otherwise specified) in Ontario, 
Canada.   
Methods 
We conducted a retrospective-cohort study of 19,041 individuals with an 
ED from January 1, 1990, to December 31, 2013 using administrative 
healthcare data. The outcome of interest was death. Excess mortality 
was assessed using standardized mortality ratios (SMRs) and potential 
years of life lost (PYLL). Cox proportional hazards regression models 
were used to examine socio-demographic and medical comorbidities 
associated with greater mortality risk. 
Results 
The ED cohort had 17,108 females (89.9%) and 1,933 males (10.1%). 
The all-cause mortality for the entire ED cohort was five times higher 
than expected compared to the Ontario population (SMR = 5.06; 95% 
CI:4.82-5.30). SMRs were higher for males (SMR=7.24; 95% CI: 6.58-
7.96) relative to females (SMR=4.59; 95% CI: 4.34-4.85), overall and in 
all age groups in the cohort. For both sexes, the ED cohort PYLL was 





Conclusions and Relevance 
Patients with EDs experience five to seven times higher mortality rates 
compared to the overall population. There is an urgent need to 
understand the mortality risk factors to improve health outcomes among 
individuals with eating disorders. 
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12 Question: What is the mortality rate for individuals with eating disorders? 
13 Findings: This study of 19,041 individuals with eating disorders found that eating disorders are 
14 associated with an elevated risk of premature of death. The all-cause mortality for the entire cohort 
15 was five times higher than expected compared to the general population. Standardised mortality ratios 
16 were higher overall for males (SMR = 7.24) relative to females (SMR = 4.59). 
17 Meaning: Individuals with eating disorders experience excess premature mortality compared to the 
18 general population. These findings highlight the need to develop focused interventions for this group 
19 to improve health outcomes.
20







23 Individuals with eating disorders (EDs) have a high mortality risk. Few population-based studies have 
24 estimated mortality risk in EDs other than anorexia nervosa. 
25 Aims
26 To investigate all-cause mortality within a population-based cohort of individuals who received 
27 hospital-based care for any ED (anorexia nervosa, bulimia nervosa or ED not otherwise specified) in 
28 Ontario, Canada.  
29 Methods
30 We conducted a retrospective-cohort study of 19,041 individuals with an ED from January 1, 1990, to 
31 December 31, 2013 using administrative healthcare data. The outcome of interest was death. Excess 
32 mortality was assessed using standardized mortality ratios (SMRs) and potential years of life lost 
33 (PYLL). Cox proportional hazards regression models were used to examine socio-demographic and 
34 medical comorbidities associated with greater mortality risk.
35 Results
36 The ED cohort had 17,108 females (89.9%) and 1,933 males (10.1%). The all-cause mortality for the 
37 entire ED cohort was five times higher than expected compared to the Ontario population (SMR = 5.06; 
38 95% CI:4.82-5.30). SMRs were higher for males (SMR=7.24; 95% CI: 6.58-7.96) relative to females 
39 (SMR=4.59; 95% CI: 4.34-4.85) overall, and in all age groups in the cohort. For both sexes, the ED 
40 cohort PYLL was more than 6 times higher than the expected PYLL in the Ontario population. 
41 Conclusions and Relevance
42 Patients with EDs experience five to seven times higher mortality rates compared to the overall 
43 population. There is an urgent need to understand the mortality risk factors to improve health 
44 outcomes among individuals with eating disorders. 
45 Declaration of Interest
46 None.
47 Keywords:





48 Eating disorders; anorexia nervosa; bulimia nervosa; EDNOS; mortality; standardized mortality ratio; 
49 male; female
50
51 WORD COUNT: 3,270 (excludes abstract and key points)
52
53 Relevance Statement
54 Eating disorders, including anorexia nervosa, bulimia nervosa, and eating disorders not otherwise specified, are 
55 associated with high illness burden, including mortality. This study uses population-based data to estimate 
56 standardized mortality ratios (SMRs) comparing the rate of mortality amongst individuals with eating disorders 
57 to the general population in Ontario, Canada. The SMR for individuals with eating disorders was 5.06, reflecting 
58 a 5-fold increase in mortality risk for individuals with eating disorders. For males, the risk was 7-fold higher (SMR 
59 - 7.24). Understanding the risk factors for the increased mortality in eating disorders is critical to reduce 
60 mortality in this clinical population.






62 Eating disorders are associated with a high risk of mortality and high illness burden including 
63 major depression, post-traumatic stress disorder, and chronic conditions including cardiovascular, 
64 heart failure, musculoskeletal and renal complications as observed in clinical population samples. (1-4) 
65 One meta-analysis reported an overall elevated mortality rate for eating disorders (anorexia nervosa, 
66 bulimia nervosa, and eating disorder not otherwise specified), which in some instances was much 
67 higher than other psychiatric disorders. (5) Eating disorders have also been associated with high health 
68 care costs, related to both psychiatric and non-psychiatric hospitalizations. Previous research has 
69 found that direct health care costs for individuals hospitalised for an eating disorder were about $48 
70 million, with higher costs for those under the age of 20 and those 65 and older. (1) However, few 
71 population-based surveillance studies estimating incidence, prevalence and mortality in eating 
72 disorders have been published (2, 6, 7), with the literature on the epidemiology and outcomes of 
73 eating disorders having significant limitations such as small sample sizes and few large-scale mental 
74 health surveillance studies.(2, 6) 
75 Most of the literature reporting on mortality in eating disorder patients comes from studies 
76 examining cohorts in specific treatment settings, which are difficult to compare given the wide 
77 variability in treatment target populations, insurance coverage and other selection biases. (8, 9) 
78 Several mortality studies report only crude case fatality rates (i.e., they report on deaths among 
79 patients with no comparison group or adjustment for expected mortality in the same age population); 
80 other studies are limited in sample size or scope and report only on anorexia nervosa and/or only 
81 examine female patients.(9, 10) Eating disorders have been misperceived as rare perhaps due to 
82 limited awareness of the available data on the burden of disease or a misconception that only the most 





83 severe cases experience a severe burden. (11, 12) Furthermore, the lack of comprehensive data on 
84 eating disorders that includes both males and females has made it difficult to estimate all-cause and 
85 cause-specific mortality among this population.
86 This study describes all-cause mortality rates within a population-based cohort of patients with 
87 an eating disorder in a context of universal public health care funding.  Excess mortality among these 
88 patients was estimated relative to the general population without an eating disorder using 
89 standardized mortality ratios (SMRs) and potential years of life lost (PYLL) (in total and attributable to 
90 eating disorders).  In addition, factors associated with increased hazard of mortality within the ED 
91 cohort were examined including patient socio-demographic and comorbidity measures as well as 




96 This study examines a population-based, retrospective cohort of individuals who received care 
97 for an eating disorder in any hospital in Ontario from January 1, 1990, to December 31, 2013.  The 
98 cohort was followed, through record-linkage, until date of death or December 31, 2013, the latest date 
99 possible based on data availability at the time of the analysis). 
100 Data sources
101 We made use of administrative health care data available through ICES in Toronto, Ontario. 
102 ICES is an independent non-profit organization funded by the Ontario Ministry of Health and holds an 
103 inventory of coded and linkable health datasets, encompassing much of the publicly funded 
104 administrative health services records for the Ontario population eligible for universal health coverage 





105 since 1986. This data repository includes individual-level, linkable longitudinal data on most publicly 
106 funded health care services.  The Registered Persons Database (RPDB), a population-based registry, 
107 contains anonymized demographic data on all insured members of the universal Ontario Health 
108 Insurance Plan (OHIP), such as sex, date of birth, urban or rural dwelling information and 
109 neighbourhood-level income (measured in quintiles at the census tract level).  Information on date and 
110 cause of death (where applicable) were obtained from the Ontario Registry General-Death Vital 
111 Statistics.  Hospital admissions and associated diagnostic codes used to define the cohort were 
112 obtained from the following health care administrative databases maintained by the Canadian Institute 
113 for Health Information: Discharge Abstract Database (DAD) for non-mental health admissions and 
114 National Ambulatory Care Reporting System (NACRS) for emergency department visits.  Psychiatric 
115 hospitalization records were obtained from the Ontario Mental Health Reporting System (OMHRS) 
116 database.
117 Co-morbidity data for chronic medical conditions were obtained via the following validated 
118 patient cohorts and registries developed, linked and analyzed at ICES including: Ontario Congestive 
119 Heart Failure (CHF) Database; Chronic Obstructive Pulmonary Disease (COPD) Database; Ontario 
120 Diabetes Database (ODD); Ontario Asthma Database; Ontario HIV Database  and Ontario Cancer 
121 Registry (OCR). These datasets have been described elsewhere. (13) 
122 Derivation of the eating disorder patient cohort
123 Individuals were included if they received an eating disorder diagnosis during an emergency 
124 department visit, medical hospitalization, or psychiatric hospitalization from 1990 to 2013. The first 
125 diagnosis from any of these data sources was determined as the cohort entry date. Cohort 
126 development and analyses were carried out with linked administrative health care data holdings at 





127 ICES.  Diagnostic codes used to identify eating disorder patients included: ICD-9 codes 307.1 (anorexia 
128 nervosa), 307.51 (bulimia nervosa), 307.50 (eating disorders not otherwise specified); ICD-10 codes 
129 F50.0 (eating disorders), F50.1 (anorexia nervosa), F50.2, F50.3 (bulimia nervosa), F50.8, F50.9 
130 (EDNOS), and DSM-IV codes 307.1 (anorexia nervosa), 307.51 (bulimia nervosa), 307.50 (EDNOS). We 
131 restricted our study to these three ED diagnoses because the publicly-funded services in Ontario focus 
132 on the treatment of these ED diagnoses. ED diagnosis codes do not apply to children under the age of 
133 5. Furthermore, children ages 5 to 9 were excluded as the small number of deaths precluded reporting 
134 under Ontario privacy regulations. We excluded individuals who ceased to be publicly insured for 
135 health care at date of cohort entry. This approach resulted in a cohort of 19,041 individuals with and 
136 eating disorder diagnosis (including all patients deceased or alive to the end of December 31, 2013). 
137 The development of this cohort, restricted to individuals alive as of January 1,2014, has also 
138 been described elsewhere. (14) 
139 Analysis
140 Mortality rates were estimated for the full cohort and were reported as deaths per 1,000 
141 person-years of observation time, overall and by sex (female and male), calendar year (from 1990 to 
142 2013), and age groups.  Person-years of follow-up were segregated by sex, calendar year and age 
143 attained over follow-up (to end of follow-up, or death) for each cohort member.  This was achieved 
144 using Lexis expansion tools for cohort data using Stata 14 (StataCorp. 2015. Stata Statistical Software: 
145 Release 14. College Station, TX: StataCorp LP).  Excess mortality in the eating disorder population, 
146 relative to the underlying Ontario population, was illustrated in several ways including SMRs, PYLL in 
147 the cohort, and proportion of PYLL attributable to eating disorder.  





148 SMRs were estimated using the indirect method.(15) SMRs were defined as the number of 
149 observed deaths in the eating disorder cohort divided by the number of expected deaths in the cohort 
150 if the eating disorder cohort had had the same sex- and age-specific mortality experience as the 
151 underlying Ontario population.  Expected mortality rates in the general population were obtained 
152 using all Ontario deaths in 2011 and corresponding data for the 2011 Census year.  SMRs were 
153 presented with exact Poisson-based 95% confidence intervals.  
154 Person Years of Life Lost (PYLL) within the eating disorder cohort were estimated as the sum of 
155 all years of life lost before age 75 (16) for observed deaths among patients with an eating disorder 
156 (expressed as PYLL per 1,000 persons).  Expected and excess (eating disorder attributable) PYLL values 
157 were also estimated using expected deaths from Ontario 2011 standard mortality rates.  The 
158 theoretical percent of total PYLL attributable to being in the eating disorder cohort (relative to the 
159 underlying population) was defined as attributable PYLL = (total cohort PYLL – expected PYLL)/ total 
160 cohort PYLL and expressed as a percentage. 
161 Socio-demographic factors associated with higher risk of mortality within the cohort were 
162 examined using Cox Proportional Hazard regression models for all-cause mortality.   Patients who 
163 entered the cohort with an eating disorder diagnosis on the same day as death contributed no follow-
164 up time and were excluded from the survival models (N=5).  Separate Cox models were estimated for 
165 patients aged 10 to 44 at entry and those 45 and older.  Patient socio-demographic characteristics 
166 considered were age, sex and calendar year over the period of the study, as well as neighbourhood-
167 level household income quintile and rurality of residence.  Models examining the effect of socio-
168 demographic variables were then further adjusted for medical co-morbidity (i.e., chronic conditions, 





169 defined beforehand). The adjusted models included six chronic conditions derived from validated 
170 cohorts through administrative databases.  
171 Model diagnostics were performed and indicated no violations of assumptions.  This included 
172 confirmation of the validity of a linear effect of age as a continuous covariate in the exponential Cox 
173 model, assessment for non-violation of the assumption of proportional hazards, and lack of excess 
174 multi-collinearity. 
175 Ethics and approvals
176 ICES is an independent, non-profit research institute whose legal status under Ontario’s health 
177 information privacy law allows it to collect and analyze health care and demographic data, without 
178 consent, for health system evaluation and improvement. Thus, the use of data in this project was 
179 authorized under section 45 of Ontario’s Personal Health Information Protection Act, which does not 
180 require review by a Research Ethics Board.   The project was approved by the Research Ethics Board at 
181 University Health Network, Toronto.
182






184 Baseline characteristics of the eating disorder cohort are presented in Table 1. Of the 19,041 
185 cohort members, 17,108 were female (89.9%) and 1,933 were male (10.1%).  Age at cohort entry 
186 ranged from 10 to over 85 years of age, but 88.9% of the population entered the cohort between the 
187 ages of 14 and 44.  Most of the cohort (88.8%) resided in urban centres. A greater percentage of the 
188 cohort lived in middle to low-income neighbourhoods, with 37.4% in the lowest neighbourhood level 
189 income category and 18.0% in the middle-income neighbourhood level income category. Categories for 
190 eating disorder-specific diagnoses at cohort entry revealed multiple diagnoses for the same individual 
191 over time; 31.8% of the cohort had anorexia nervosa alone or in combination with bulimia nervosa 
192 and/or eating disorder not otherwise specified (EDNOS); 35.1% of the cohort had a diagnosis of EDNOS 
193 alone at enrolment.  Eating disorder diagnoses were also comorbid with other medical conditions 
194 including asthma (27.0%), diabetes (8.9%), cancer (4.6%) and congestive heart failure (3.5%).
195 Table 2 presents descriptive statistics for the mortality follow-up analysis of this cohort, 
196 including total person-years of follow up and observed deaths, for the whole cohort and by age group 
197 and sex.  Mortality rates and SMRs by age group and sex are also presented in Table 2.  For the entire 
198 eating disorder cohort and across all age groups, the all-cause mortality rate was five times higher than 
199 expected based on mortality rates in the Ontario population (marginal SMR = 5.06; 95% CI:4.82-5.30). 
200 Peak values for SMRs were observed among adults from approximately 30 to 44 years of age.  
201 Mortality rates and SMRs were unstable for individuals 10 to 14 due to small number of deaths.  SMRs 
202 were higher for male eating disorder patients, relative to female, overall and in all age groups.  For 
203 females, the marginal SMR was 4.59 (95% CI: 4.34-4.85) while for males it was 7.24 (95% CI: 6.58-7.96).  





204 Excess mortality is further illustrated in Figure 1, which presents cohort and population mortality rates 
205 (per 1,000 population) by age and sex as well as age-sex specific SMRs.  
206 The overall expected PYLL (based on expected numbers of deaths in the cohort using the 2011 
207 Ontario age-specific death rates) was estimated at 29.54 years per 1,000 population (95% CI: 28.7-
208 30.4) and similar for each sex separately (Appendix Table 1).  Within the eating disorder cohort, 
209 estimated total PYLL before age 75 equalled 191.6 per 1,000 population (95% CI:  189.4-193.8), for 
210 both sexes, combined.  Years of life lost per 1,000 population was higher for males (PYLL within 
211 cohort=375.6; 95% CI: 364.7-386.8) relative to females (PYLL within cohort=174.1; 95% CI: 171.9-
212 176.3).  For both sexes, the excess PYLL attributable to experiencing an eating disorder was 84%.  For 
213 female eating disorder patients, it was estimated that 83% of PYLL were attributable to being in the 
214 eating disorder cohort; for male eating disorder patients, this value was 92%.  Among all Ontario ED 
215 patients, over the period of this study, it was estimated that 24,773 years of life were lost due to eating 
216 disorder, before the age of 75. 
217 Cox survival models on all-cause mortality, controlling for the effects of demographic 
218 characteristics, appear in Table 3.  For both age groups (10-44 and >=45 years of age), older age (as a 
219 continuous, linear term) and male sex were associated with statistically significant increased mortality 
220 risk and adjusted hazard ratio of 1.91 in both age groups.  Additionally, mortality declined over 
221 calendar years in the analysis showing a statistically significant effect of calendar year on the 
222 downward trend in mortality over time (adjusted hazard ratio of 0.9, year over year).  In addition, the 
223 pattern of association with household income quintile was not a simple linear association, but rather a 
224 U-shaped pattern.  Higher total mortality hazard ratios were observed in the highest and lowest 
225 income quintiles, relative to household income quintiles in the middle.  





226 Fully adjusted models for age, sex and calendar year resulted in opposite findings for rurality in 
227 the analyses for cohort members under and over 45 years of age.  Rural residence was associated with 
228 lower mortality for cohort members under the age of 45 but higher mortality risk for cohort members 
229 45 or older.  Control variables for non-ED chronic medical conditions (CHF, COPD, cancer and HIV) were 
230 all positively associated with higher mortality ratios with the exceptions of inverse associations for 
231 asthma and diabetes diagnoses within cohort members age 45 and over.  For cohort members ages 44 
232 and younger, having a diagnosis of CHF, cancer, diabetes and HIV was positively associated with higher 
233 mortality ratios.  We observed a simple linear trend toward lower mortality with calendar year of entry 
234 into the cohort.  This cannot be separated from a general trend in improved survival in the population 
235 as age-sex specific mortality risk expected in the population are not updated for each calendar year but 
236 based on census years (here based on the 2011 Canadian census). 
237
238 DISCUSSION
239 The purpose of this study was to estimate the excess mortality and burden associated with 
240 eating disorders using comprehensive population-based data.  Notably, this study is among the few 
241 internationally that have made use of a population-based eating disorder cohort and to have provided 
242 SMR estimates specific to both female and male patients.  Our findings show that individuals with 
243 eating disorders diagnosed in hospital settings had a mortality rate of approximately 5-fold higher than 
244 the general population, with more than 80% of life lost before the age of 75 for females and males.  
245 In female eating disorder patients, we found a roughly five-fold mortality rate relative to the 
246 general population.  This is similar in magnitude to what has been reported in two international meta-
247 analyses (5, 8) and similar in magnitude to SMRs reported specifically for anorexia nervosa (anorexia 





248 nervosa being the eating disorder diagnosis with the highest SMRs).  Whilst studies have reported on 
249 the lifetime prevalence of eating disorders in males ranging from 0.1 to 2.0 for all types,(2, 9) few 
250 studies have reported on the mortality rates among males with eating disorders and those studies tend 
251 to report exclusively on anorexia nervosa.(17, 18) Our study thus makes a novel and important 
252 contribution to the sparse literature on male eating disorder patients and their mortality experience, 
253 with a substantially larger sample of male eating disorder patients. 
254 The SMRs observed in males were almost 2-fold higher than in females.  This observation of 
255 higher mortality in males with eating disorders is particularly concerning as there is evidence to 
256 suggest that males are less likely to self-identify or be identified with eating disorders unless the illness 
257 severity is are extremely high. Additionally, eating disorder treatment centres are less likely to accept 
258 male patients (19, 20). Gender and cultural differences in help-seeking behaviours in male eating 
259 disorder patient may result in services being less accessible, contributing to worse outcomes.  This 
260 highlights the need for enhanced case-identification, research and services for male eating disorder 
261 patients to improve outcomes (21). We also found that mortality risk was higher amongst younger 
262 individuals within the cohort and individuals living in the lowest income neighbourhoods, highlighting 
263 issues related to equity of access and quality of care; this warrants further investigation.
264 While there have been two meta-analyses estimating ED-related mortality, (5, 8) the existing 
265 literature has methodological issues including a lack of population-based surveillance data (limited to 
266 sub-regional studies and registries from restricted clinical practices(3, 22)), selection of study 
267 population, identification of cases, and small sample size.(9, 10, 17, 23-25) 
268 Finally, our results demonstrate the degree to which patients with EDs also experience 
269 important medical conditions and co-morbidities, such as congestive heart failure, diabetes, COPD and 





270 hypertension amongst others. Mechanisms through which EDs may have a causal impact on diverse 
271 chronic diseases have been described elsewhere. (4)
272
273 STRENGTHS AND LIMITATIONS
274 A major strength of our study was the use of a population-based sample, which is more 
275 representative and generalizable than cohorts based on a sample of hospitalised patients from 
276 individual treatment centres or insurance programs. An additional methodological strength was the 
277 use of the recommended SMR method, which is replicable and well established, to report excess 
278 mortality relative to the underlying population as well as controlling for sex and age through 
279 standardization (as opposed to merely reporting case-fatality rates within the clinical cohort).
280 One major limitation is the lack of validation of our algorithm for case-detection, which relied 
281 on hospital contact data and not outpatient contact data.  This may bias towards higher severity of 
282 cases and may also truncate the time between illness identification and mortality, which could result in 
283 an overestimation of mortality rates.(26) These are limitations of all research involving clinical cohorts 
284 based on administrative or insured services data.  These inherent limitations of the best data available 
285 underscore how important it is to have disease registries for eating disorders established 
286 internationally, with high quality clinical measures, which are available only in localized clinical 
287 research cohorts (22).  Moreover, the lack of data on ethnicity did not allow us to produce ethnic-
288 specific SMRs; future research should seek to address this limitation. Finally, this study included a 
289 specific group of ED diagnoses (anorexia nervosa, bulimia nervosa, and ED NOS) for which treatment is 
290 available in Ontario’s publicly funded system. We did not include other eating disorder diagnoses such 





291 as binge-eating disorder, and it is unclear whether the findings from our study would generalize to a 
292 broader array of eating disorder diagnoses.
293
294 IMPACT AND RELEVANCE
295 In summary, our study provides evidence of the high mortality rate associated with eating 
296 disorder diagnoses.  Furthermore, males with eating disorders have a higher risk of mortality than 
297 females, which underscores the importance of detecting and treating eating disorders in males even 
298 though they are relatively low in prevalence.  These findings are consistent with previous research on 
299 excess mortality; we effectively show the marked gender differences in risk of mortality and actual 
300 excess mortality in the eating disorder population.  Historically, the burden of eating disorders, 
301 including mortality, has been documented to a lesser extent compared to studies of other psychiatric 
302 conditions despite its prevalence and high mortality rate. 
303 This study serves to highlight the need for ongoing population-based surveillance of eating 
304 disorder burden. Early intervention in eating disorders is known to be effective (27) (28) and presents 
305 an opportunity to reduce the mortality impact (high and early onset mortality) of these conditions. The 
306 inclusion of eating disorders amongst other disorders identified as high priority for improved 
307 surveillance and burden of disease data in mental health also highlights a need for better detection of 
308 and treatment of eating disorders and associated psychiatric comorbidities to improve long-term 
309 outcomes.  
310
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405 Tables and Figures
406 Table 1: Demographic and Clinical Characteristics of the Eating Disorder cohort
VARIABLE Female Male TOTAL P-VALUE
Sex differences 
(unadjusted)
N=17,108 N=1,933 N=19,041  
Age at first diagnosis, Mean ± SD 25.76 ± 15.44 37.37 ± 23.91 26.94 ± 16.87 <0.001
N (% of 
cohort, 
females)
N (% of 
cohort, 
males)
N (% of cohort)
Age group at diagnosis
10_13 1,359 (7.9) 197 (10.2) 1,556 (8.2)
14_17 5,613 (32.8) 370 (19.1) 5,983 (31.4)  
18_24 4,015 (23.5) 279 (14.4) 4,294 (22.6)  
25_44 4,231 (24.7) 443 (22.9) 4,674 (24.5)  
45_64 1,201 (7.0) 279 (14.4) 1,480 (7.8)  
65_84 519 (3.0) 290 (15.0) 809 (4.2)  
>=85 170 (1.0) 75 (3.9) 245 (1.3)  
Neighbourhood Income Quintile
1 (low) 3,164 (18.5) 434 (22.5) 3,598 (18.9) <0.001
2 (medium-low) 3,149 (18.4) 366 (18.9) 3,515 (18.5)  
3 (medium) 3,143 (18.4) 365 (18.9) 3,508 (18.4)  
4 (medium-high) 3,460 (20.2) 377 (19.5) 3,837 (20.2)  
5 (high) 4,105 (24.0) 374 (19.3) 4,479 (23.5)  
Missing 87 (0.5) 17 (0.9) 104 (0.5)  
Rural residence
No 15,186 (88.8) 1,710 (88.5) 16,896 (88.7) 0.691
Yes 1,922 (11.2) 223 (11.5) 2,145 (11.3)  
Clinical Characteristics
Eating Disorder Diagnosis at 
cohort entry
AN and BN 121 (0.7) 7 (0.4) 128 (0.7) <0.001
AN and EDNOS * * 55 (*)  
AN only 5,437 (31.8) 398 (20.6) 5,835 (30.6)  
AN, BN, and EDNOS 291 (1.7) 7 (0.4) 298 (1.6)  
BN and EDNOS 2,981 (17.4) 353 (18.3) 3,334 (17.5)  
BN only 2,218 (13.0) 137 (7.1) 2,355 (12.4)  
EDNOS only 6,008 (35.1) 1,028 (53.2) 7,036 (37.0)  
Co-morbidity
Asthma 4,759 (27.8) 480 (24.8) 5,239 (27.5) 0.005
Cancer 638 (3.7) 225 (11.6) 863 (4.5) <0.001
COPD 1,237 (7.2) 300 (15.5) 1,537 (8.1) <0.001





Congestive Heart Failure 472 (2.8) 190 (9.8) 662 (3.5) <0.001
Diabetes 1,390 (8.1) 343 (17.7) 1,733 (9.1) <0.001
HIV 23 (0.1) 22 (1.1) 45 (0.2) <0.001
407 Legend: SD-standard deviation; AN-Anorexia Nervosa; BN-Bulimia Nervosa; EDNOS-Eating Disorder Not Otherwise 
408 Specified; COPD- Chronic Obstructive Pulmonary Disease; HIV, Human Immuno-Deficiency Virus
409
410


















Both Sexes      
Overall 155,921.03 1672 330.85 10.88 5.1 (4.8-5.3)
15-19 22,842.62 32 6.72 1.42 4.8 (3.3-6.7)
20-24 29,121.61 59 11.57 2.04 5.1 (4.0-6.6)
25-29 25,621.18 68 10.22 2.66 6.7 (5.3-8.4)
30-34 20,068.30 84 12.04 4.19 7.0 (5.6-8.6)
35-39 14,937.13 92 10.46 6.16 8.8 (7.2-10.8)
40-44 11,810.93 107 12.99 9.06 8.2 (6.8-10.0)
45-49 9,362.66 126 16.85 13.46 7.5 (6.3-8.9)
50-54 6,407.25 116 19.86 18.10 5.8 (4.9-7.0)
55-59 3,871.77 90 18.58 23.25 4.8 (3.9-6.0)
60-64 2,232.77 83 16.3 37.17 5.1 (4.1-6.3)
65-69 1,331.44 105 15.44 78.86 6.8 (5.6-8.2)
70-74 1,012.38 113 18.53 111.62 6.1 (5.1-7.3)
75-79 875.12 137 26.78 156.55 5.1 (4.3-6.1)
80-84 765.24 180 40.25 235.22 4.5 (3.9-5.2)
85-89 474.79 172 42.87 362.26 4.0 (3.5-4.7)
90+ 292.76 104 51.06 355.24 2.0 (1.7-2.5)
Female      
Overall 142,655.30 1249 272.29 8.83 4.6 (4.3-4.9)
15-19 20980.86 25 6.21 1.20 4.0 (2.7-6.0)
20-24 27195.17 50 10.83 1.85 4.6 (3.5-6.1)
25-29 24203.29 61 9.66 2.53 6.3 (4.9-8.1)
30-34 18855.12 71 11.31 3.77 6.3 (5.0-7.9)
35-39 13822.51 80 9.68 5.79 8.3 (6.6-10.3)
40-44 10747.7 90 11.82 8.37 7.6 (6.2 -9.4)
45-49 8479.574 106 15.26 12.50 7.0 (5.7-8.4)
50-54 5761.355 94 17.86 16.32 5.3 (4.3-6.4)
55-59 3433.343 73 16.48 21.26 4.4 (3.5-5.6)
60-64 1861.803 61 13.59 32.76 4.5 (3.5-5.8)
65-69 1048.189 70 12.16 66.78 5.8 (4.6-7.3)
70-74 755.4538 67 13.82 88.69 4.9 (3.8-6.2)
75-79 653.2047 85 19.99 130.13 4.3 (3.4-5.3)
80-84 583.2382 114 30.68 195.46 3.7 (3.1-4.5)
85-89 348.6016 119 31.48 341.36 3.8 (3.2-4.5)
90+ 236.0726 80 41.17 338.88 1.9 (1.6-2.4)
Male      





Overall 1,213.18 423 58.56 34.56 7.2 (6.6-8.0)
15-19  1861.75 7 0.5 4.17 13.9 (6.6-29.2)
20-24  1926.44 9 0.74 4.85 12.1 (6.3-23.3)
25-29  1417.89 7 0.56 5.00 12.5 (6.0-26.2)
30-34 1213.182 13 0.73 10.72 17.9 (10.4-30.8)
35-39 1114.625 12 0.78 10.77 15.4 (8.7-27.1)
40-44 1063.231 17 1.17 15.99 14.5 (9.0-23.4)
45-49 883.0904 20 1.59 22.65 12.6 (8.1-19.5)
50-54 645.8871 22 2 34.06 11.0 (7.2-16.7)
55-59 438.4278 17 2.1 38.77 8.1 (5.0-13.0)
60-64 370.974 22 2.71 59.30 8.1 (5.4-12.3)
65-69 283.245 35 3.29 123.57 10.7 (7.7-14.8)
70-74 256.9281 46 4.7 179.04 9.8 (7.3-13.1)
75-79 221.9124 52 6.79 234.33 7.7 (5.8-10.1)
80-84 182.0007 66 9.57 362.64 6.9 (5.4-8.8)
85-89 126.1937 53 11.4 419.99 4.7 (3.6-6.1)
90+ 56.68994 24 9.89 423.36 2.4 (1.6-3.6)
412 *SMRs are stratified by age-group where age is a time-dependent covariate reflecting age attained during follow-up as 
413 opposed to at baseline.  Time-dependent age calculated using STATA command STSPLIT.
414 Legend: SMR - standardized mortality ratio; CI – confidence interval























Age** 10 to 44- N=16,507
Age** (integer, continuous) 1.07 (1.06 – 1.07) 1.05 (1.05 – 1.06) < 0.001 (1)
Calendar year (integer, continuous) 0.90 (0.89 – 0.90) 0.91 (0.91 – 0.92) < 0.001 (1)
Sex (male versus female) 2.06 (1.92 – 2.21) 1.91 (1.78 – 2.05) < 0.001 (1)
Neighbourhood income quintile
    1 (low)
    2 (medium-low)
    3 (medium)
    4 (medium-high)























Rural residence (versus urban residence) 0.65 (0.60 – 0.71) 0.69 (0.63 - 0.75) < 0.001 (1)
Medical co-morbidity indicators (binary):
   Congestive heart failure 2.45 (2.23 – 2.69) < 0.001 (1)
   COPD      1.07 (0.99 – 1.14) 0.07 (1)
   Cancer 2.43 (2.25 – 2.62) < 0.001 (1)
   Asthma 1.01 (0.96 – 1.06) 0.76 (1)
   Diabetes 1.75 (1.65 – 1.86) < 0.001 (1)
   HIV 2.16 (1.75 – 2.67) < 0.001 (1)
Age** 45 and older- N=2532
Age** (integer, continuous) 1.08 (1.08 – 1.08) 1.07 (1.07 – 1.08) < 0.001 (1)
Calendar year (integer, continuous) 0.88 (0.87 – 0.88) 0.89 (0.88 – 0.89) < 0.001 (1)
Sex (male versus female) 1.92 (1.82 – 2.01) 1.91 (1.82 – 2.02) < 0.001 (1)
Neighbourhood income quintile:
    1 (low)
    2 (medium-low)
    3 (medium)
    4 (medium-high)























Rural residence (versus urban residence) 1.27 (1.19 – 1.35) 1.22 (1.15 – 1.30) < 0.001 (1)
Medical co-morbidity indicators (binary):
   Congestive heart failure 1.32 (1.25 – 1.38) < 0.001 (1)
   COPD 1.06 (1.01 – 1.11) < 0.03 (1)
   Cancer 2.24 (2.14 – 2.35) < 0.001 (1)
   Asthma 0.94 (0.89 – 0.99) 0.03 (1)
   Diabetes 0.89 (0.86 – 0.94) < 0.001 (1)
   HIV 2.06 (1.59 – 2.66) < 0.001 (1)
417 * Likelihood ratio test for removal of covariate from fully adjusted model shown.  
418 ** Age is defined as time-dependent covariate, meaning age of cohort member attained over follow-up and not at baseline. 
419 Time-dependent age is calculated using STATA command STSPLIT. 
420 Legend: COPD- Chronic Obstructive Pulmonary Disease; HIV, Human Immuno-Deficiency Virus
421





422 Appendix Table 1: Age-Sex matched person years of life lost and 95% CI in ED cohort and Ontario population in 
423 2011
ED Cohort Ontario Population Excess PYLL (%)
PYLL (95% CI) PYLL (95% CI)
Both 
Sexes 191.5 (189.3-193.7) 29.6 (28.8-30.5) 85%
Male 375.4 (364.4-386.6) 29.6 (28.7-30.5) 92%
Female 174.8 (172.6-177.0) 29.7 (26.6-32.7) 83%
424
425 Legend: ED – eating disorders; CI – confidence interval; PYLL – Person Years of Life Lost
426





Figure 1: Standardized mortality ratios-by sex and age-group, all-cause mortality rates observed within the eating disorders cohort (1991-2013) 
and Ontario (2011) mortality rates
Y1 axis label (left) Standardized Mortality Ratio (SMR)
Y2 axis label (right) Observed morality rate (per 1000 person years)
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Question: What is the mortality rate for individuals with eating disorders? 
Findings: This study of 19,041 individuals with eating disorders found that eating disorders are 
associated with an elevated risk of premature of death. The all-cause mortality for the entire cohort 
was five times higher than expected compared to the general population. Standardised mortality ratios 
were higher overall for males (SMR = 7.24) relative to females (SMR = 4.59). 
Meaning: Individuals with eating disorders experience excess premature mortality compared to the 
general population. These findings highlight the need to develop focused interventions for this group 
to improve health outcomes.







Individuals with eating disorders (EDs) have a high mortality risk. Few population-based studies have 
estimated mortality risk in EDs other than anorexia nervosa. 
Aims
To investigate all-cause mortality within a population-based cohort of individuals who received 
hospital-based care for any ED (anorexia nervosa, bulimia nervosa or ED not otherwise specified) in 
Ontario, Canada.  
Methods
We conducted a retrospective-cohort study of 19,041 individuals with an ED from January 1, 1990, to 
December 31, 2013 using administrative healthcare data. The outcome of interest was death. Excess 
mortality was assessed using standardized mortality ratios (SMRs) and potential years of life lost 
(PYLL). Cox proportional hazards regression models were used to examine socio-demographic and 
medical comorbidities associated with greater mortality risk.
Results
The ED cohort had 17,108 females (89.9%) and 1,933 males (10.1%). The all-cause mortality for the 
entire ED cohort was five times higher than expected compared to the Ontario population (SMR = 5.06; 
95% CI:4.82-5.30). SMRs were higher for males (SMR=7.24; 95% CI: 6.58-7.96) relative to females 
(SMR=4.59; 95% CI: 4.34-4.85), overall, and in all age groups in the cohort. For both sexes, the ED 
cohort PYLL was more than 6 times higher than the expected PYLL in the Ontario population. 
Conclusions and Relevance
Patients with EDs experience five to seven times higher mortality rates compared to the overall 
population. There is an urgent need to understand the mortality risk factors to improve health 









Eating disorders; anorexia nervosa; bulimia nervosa; EDNOS; mortality; standardized mortality ratio; 
male; female
WORD COUNT: 3,519 270 (excludes abstract and key points)
Relevance Statement
Eating disorders, including anorexia nervosa, bulimia nervosa, and eating disorders not otherwise specified, are 
associated with high illness burden, including mortality. This study uses population-based data to estimate 
standardized mortality ratios (SMRs) comparing the rate of mortality amongst individuals with eating disorders 
to the general population in Ontario, Canada. The SMR for individuals with eating disorders was 5.06, reflecting 
a 5-fold increase in mortality risk for individuals with eating disorders. For males, the risk was 7-fold higher (SMR 
- 7.24). Understanding the risk factors for the increased mortality in eating disorders is critical to reduce 
mortality in this clinical population.






Eating disorders are associated with a high risk of mortality and high illness burden including 
major depression, post-traumatic stress disorder, and chronic conditions including cardiovascular, 
heart failure, musculoskeletal and renal complications as observed in clinical population samples. (1-4) 
One meta-analysis reported an overall elevated mortality rate for all eating disorders (anorexia 
nervosa, bulimia nervosa, and eating disorder not otherwise specified)types, which in some instances 
wasere much higher than other psychiatric disorders. (5) Eating disorders have also been associated 
with high health care costs, related to both psychiatric and non-psychiatric hospitalizations. Previous 
research has found that direct health care costs for individuals hospitalised for an eating disorder were 
about $48 million, with higher costs for those under the age of 20 and those 65 and older. (1) However, 
few population-based surveillance studies estimating incidence, prevalence and mortality in eating 
disorders have been published (2, 6, 7), with the literature on the epidemiology and outcomes of 
eating disorders having significant limitations such as small sample sizes and few large-scale mental 
health surveillance studies.(2, 6) 
Most of the literature reporting on mortality in eating disorder patients comes from studies 
examining cohorts in specific treatment settings, which are difficult to compare given the wide 
variability in treatment target populations, insurance coverage and other selection biases. (8, 9) 
Several mortality studies report only crude case fatality rates (i.e., they report on deaths among 
patients with no comparison group or adjustment for expected mortality in the same age population); 
other studies are limited in sample size or scope and report only on anorexia nervosa and/or only 
examine female patients.(9, 10) Eating disorders have been misperceived as rare perhaps due to 
limited awareness of the available data on the burden of disease or a misconception that only the most 





severe cases experience a severe burden. (11, 12) Furthermore, the lack of comprehensive data on 
eating disorders that includes both males and females has made it difficult to estimate all-cause and 
cause-specific mortality among this population.
This study describes all-cause mortality rates within a population-based cohort of patients with 
an eating disorder in a context of universal public health care funding.  Excess mortality among these 
patients wais estimated relative to the general population without an eating disorder using 
standardized mortality ratios (SMRs) and potential years of life lost (PYLL) (in total and attributable to 
eating disorders).  In addition, factors associated with increased hazard of mortality within the ED 
cohort were examined including patient socio-demographic and comorbidity measures as well as 
indicators of health care service utilization. 
METHODS
Study design
This study examines a population-based, retrospective cohort of individuals who received care 
for an eating disorder in any hospital in Ontario from January 1, 1990, to December 31, 2013.  The 
cohort was followed, through record-linkage, until date of death or December 31, 2013, the latest date 
possible based on data availability at the time of the analysis). 
Data sources
We made use of administrative health care data available through ICES in Toronto, Ontario. 
ICES is an independent non-profit organization funded by the Ontario Ministry of Health and holds an 
inventory of coded and linkable health datasets, encompassing much of the publicly funded 
administrative health services records for the Ontario population eligible for universal health coverage 





since 1986. This data repository includes individual-level, linkable longitudinal data on most publicly 
funded health care services.  The Registered Persons Database (RPDB), a population-based registry, 
contains anonymized demographic data on all insured members of the universal Ontario Health 
Insurance Plan (OHIP), such as sex, date of birth, urban or rural dwelling information and 
neighbourhood-level income (measured in quintiles at the census tract level).  Information on date and 
cause of death (where applicable) were obtained from the Ontario Registry General-Death Vital 
Statistics.  Hospital admissions and associated diagnostic codes used to define the cohort were 
obtained from the following health care administrative databases maintained by the Canadian Institute 
for Health Information: Discharge Abstract Database (DAD) for non-mental health admissions and 
National Ambulatory Care Reporting System (NACRS) for emergency department visits.  Psychiatric 
hospitalization records were obtained from the Ontario Mental Health Reporting System (OMHRS) 
database.
Co-morbidity data for chronic medical conditions were obtained via the following validated 
patient cohorts and registries developed, linked and analyzed at ICES including: Ontario Congestive 
Heart Failure (CHF) Database; Chronic Obstructive Pulmonary Disease (COPD) Database; Ontario 
Diabetes Database (ODD); Ontario Asthma Database; Ontario HIV Database  and Ontario Cancer 
Registry (OCR). These datasets have been described elsewhere. (13) 
Derivation of the eating disorder patient cohort
Individuals were included if they received an eating disorder diagnosis during an emergency 
department visit, medical hospitalization, or psychiatric hospitalization from 1990 to 2013. The first 
diagnosis from any of these data sources was determined as the cohort entry date. Cohort 
development and analyses were carried out with linked administrative health care data holdings at 





ICES.  Diagnostic codes used to identify eating disorder patients included: ICD-9 codes 307.1 (anorexia 
nervosa), 307.51 (bulimia nervosa), 307.50 (eating disorders not otherwise specified); ICD-10 codes 
F50.0 (eating disorders), F50.1 (anorexia nervosa), F50.2, F50.3 (bulimia nervosa), F50.8, F50.9 
(EDNOS), and DSM-IV codes 307.1 (anorexia nervosa), 307.51 (bulimia nervosa), 307.50 (EDNOS). We 
restricted our study to these three ED diagnoses because the publicly-funded services in Ontario focus 
on the treatment of these ED diagnoses. ED diagnosis codes do not apply to children under the age of 
5. Furthermore, children ages 5 to 9 were excluded as the small number of deaths precluded reporting 
under Ontario privacy regulations. We excluded individuals who ceased to be publicly insured for 
health care at date of cohort entry. This approach resulted in a cohort of 19,041 individuals with and 
eating disorder diagnosis (including all patients deceased or alive to the end of December 31, 2013). 
The development of this cohort, restricted to individuals alive as of January 1,2014, has also 
been described elsewhere. (14) 
Analysis
Mortality rates were estimated for the full cohort and were reported as deaths per 1,000 
person-years of observation time, overall and by sex (female and male), calendar year (from 1990 to 
2013), and age groups.  Person-years of follow-up were segregated by sex, calendar year and age 
attained over follow-up (to end of follow-up, or death) for each cohort member.  This was achieved 
using Lexis expansion tools for cohort data using Stata 14 (StataCorp. 2015. Stata Statistical Software: 
Release 14. College Station, TX: StataCorp LP).  Excess mortality in the eating disorder population, 
relative to the underlying Ontario population, was illustrated in several ways including SMRs, PYLL in 
the cohort, and proportion of PYLL attributable to eating disorder.  





SMRs were estimated using the indirect method.(15) SMRs were defined as the number of 
observed deaths in the eating disorder cohort divided by the number of expected deaths in the cohort 
if the eating disorder cohort had had the same sex- and age-specific mortality experience as the 
underlying Ontario population.  Expected mortality rates in the general population were obtained 
using all Ontario deaths in 2011 and corresponding data for the 2011 Census year.  SMRs were 
presented with exact Poisson-based 95% confidence intervals.  
Person Years of Life Lost (PYLL) within the eating disorder cohort were estimated as the sum of 
all years of life lost before age 75 (16) for observed deaths among patients with an eating disorder 
(expressed as PYLL per 1,000 persons).  Expected and excess (eating disorder attributable) PYLL values 
were also estimated using expected deaths from Ontario 2011 standard mortality rates.  The 
theoretical percent of total PYLL attributable to being in the eating disorder cohort (relative to the 
underlying population) was defined as attributable PYLL = (total cohort PYLL – expected PYLL)/ total 
cohort PYLL and expressed as a percentage. 
Socio-demographic factors associated with higher risk of mortality within the cohort were 
examined using Cox Proportional Hazard regression models for all-cause mortality.   Patients who 
entered the cohort with an eating disorder diagnosis on the same day as death contributed no follow-
up time and were excluded from the survival models (N=5).  Separate Cox models were estimated for 
patients aged 10 to 44 at entry and those 45 and older.  Patient socio-demographic characteristics 
considered were age, sex and calendar year over the period of the study, as well as neighbourhood-
level household income quintile and rurality of residence.  Models examining the effect of socio-
demographic variables were then further adjusted for medical co-morbidity (i.e., chronic conditions, 





defined beforehand). The adjusted models included six chronic conditions derived from validated 
cohorts through administrative databases.  
Model diagnostics were performed and indicated no violations of assumptions.  This included 
confirmation of the validity of a linear effect of age as a continuous covariate in the exponential Cox 
model, assessment for non-violation of the assumption of proportional hazards, and lack of excess 
multi-collinearity. 
Ethics and approvals
ICES is an independent, non-profit research institute whose legal status under Ontario’s health 
information privacy law allows it to collect and analyze health care and demographic data, without 
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Baseline characteristics of the eating disorder cohort are presented in Table 1. Of the 19,041 
cohort members, 17,108 were female (89.9%) and 1,933 were male (10.1%).  Age at cohort entry 
ranged from 10 to over 85 years of age, but 88.9% of the population entered the cohort between the 
ages of 14 and 44.  Most of the cohort (88.8%) resided in urban centres. A greater percentage of the 
cohort lived in middle to low-income neighbourhoods, with 37.4% in the lowest neighbourhood level 
income category and 18.0% in the middle-income neighbourhood level income category. Categories for 
eating disorder- specific diagnoses at cohort entry revealed multiple diagnoses for the same individual 
over time; 31.8% of the cohort had anorexia nervosa alone or in combination with bulimia nervosa 
and/or eating disorder not otherwise specified (EDNOS); 35.1% of the cohort had a diagnosis of EDNOS 
alone at enrolment.  Eating disorder diagnoses were also comorbid with other medical conditions 
including asthma (27.0%), diabetes (8.9%), cancer (4.6%) and congestive heart failure (3.5%).
Table 2 presents descriptive statistics for the mortality follow-up analysis of this cohort, 
including total person-years of follow up and observed deaths, for the whole cohort and by age group 
and sex.  Mortality rates and SMRs by age group and sex are also presented in Table 2.  For the entire 
eating disorder cohort and across all age groups, the all-cause mortality rate was five times higher than 
expected based on mortality rates in the Ontario population (marginal SMR = 5.06; 95% CI:4.82-5.30). 
Peak values for SMRs were observed among adults from approximately 30 to 44 years of age.  
Mortality rates and SMRs were unstable for individuals 10 to 14 due to small number of deaths.  SMRs 
were higher for male eating disorder patients, relative to female, overall and in all age groups.  For 
females, the marginal SMR was 4.59 (95% CI: 4.34-4.85) while for males it was 7.24 (95% CI: 6.58-7.96).  





Excess mortality is further illustrated in Figure 1, which presents cohort and population mortality rates 
(per 1,000 population) by age and sex as well as age-sex specific SMRs.  
The overall expected PYLL (based on expected numbers of deaths in the cohort using the 2011 
Ontario age-specific death rates) was estimated at 29.54 years per 1,000 population (95% CI: 28.7-
30.4) and similar for each sex separately (Appendix Table 1).  Within the eating disorder cohort, 
estimated total PYLL before age 75 equalled 191.6 per 1,000 population (95% CI:  189.4-193.8), for 
both sexes, combined.  Years of life lost per 1,000 population was higher for males (PYLL within 
cohort=375.6; 95% CI: 364.7-386.8) relative to females (PYLL within cohort=174.1; 95% CI: 171.9-
176.3).  For both sexes, the excess PYLL attributable to experiencing an eating disorder was 84%.  For 
female eating disorder patients, it was estimated that 83% of PYLL were attributable to being in the 
eating disorder cohort; for male eating disorder patients, this value was 92%.  Among all Ontario ED 
patients, over the period of this study, it was estimated that 24,773 years of life were lost due to eating 
disorder, before the age of 75. 
Cox survival models on all-cause mortality, controlling for the effects of demographic 
characteristics, appear in Table 3.  For both age groups (10-44 and >=45 years of age), older age (as a 
continuous, linear term) and male sex were associated with statistically significant increased mortality 
risk and adjusted hazard ratio of 1.91 in both age groups.  Additionally, mortality declined over 
calendar years in the analysis showing a statistically significant effect of calendar year on the 
downward trend in mortality over time (adjusted hazard ratio of 0.9, year over year).  In addition, the 
pattern of association with household income quintile was not a simple linear association, but rather a 
U-shaped pattern.  Higher total mortality hazard ratios were observed in the highest and lowest 
income quintiles, relative to household income quintiles in the middle.  





Fully adjusted models for age, sex and calendar year resulted in opposite findings for rurality in 
the analyses for cohort members under and over 45 years of age.  Rural residence was associated with 
lower mortality for cohort members under the age of 45 but higher mortality risk for cohort members 
45 or older.  Control variables for non-ED chronic medical conditions (CHF, COPD, cancer and HIV) were 
all positively associated with higher mortality ratios with the exceptions of inverse associations for 
asthma and diabetes diagnoses within cohort members age 45 and over.  For cohort members ages 44 
and younger, having a diagnosis of CHF, cancer, diabetes and HIV was positively associated with higher 
mortality ratios.  We observed a simple linear trend toward lower mortality with calendar year of entry 
into the cohort.  This cannot be separated from a general trend in improved survival in the population 
as age-sex specific mortality risk expected in the population are not updated for each calendar year but 
based on census years (here based on the 2011 Canadian census). 
DISCUSSION
The purpose of this study was to estimate the excess mortality and burden associated with 
eating disorders using comprehensive population-based data.  Notably, this study is among the few 
internationally that have made use of a population-based eating disorder cohort and to have provided 
SMR estimates specific to both female and male patients.  Our findings show that individuals with 
eating disorders diagnosed in hospital settings had a mortality rate of approximately 5-fold higher than 
the general population, with more than 80% of life lost before the age of 75 for females and males.  
In female eating disorder patients, we found a roughly five-fold mortality rate relative to the 
general population.  This is similar in magnitude to what has been reported in two international meta-
analyses (5, 8) and similar in magnitude to SMRs reported specifically for anorexia nervosa (anorexia 





nervosa being the eating disorder diagnosis with the highest SMRs).  Whilst studies have reported on 
the lifetime prevalence of eating disorders in males ranging from 0.1 to 2.0 for all types,(2, 9) few 
studies have reported on the mortality rates among males with eating disorders and those studies tend 
to report exclusively on anorexia nervosa.(17, 18) Our study thus makes a novel and important 
contribution to the sparse literature on male eating disorder patients and their mortality experience, 
with a substantially larger sample of male eating disorder patients. 
The SMRs observed in males were almost 2-fold higher than in females.  This observation of 
higher mortality in males with eating disorders is particularly concerning as there is evidence to 
suggest that males are less likely to self-identify or be identified with eating disorders unless the illness 
severity isse are extremely high severe.; Aadditionally, , eating disorder treatment centres are less 
likely to accept or treat male patients (19, 20). Poorer outcomes in male patients with eating disorders 
may reflect gGender and cultural differences in help- seeking behaviours or referral patterns indicating 
thatin male eating disorder patient may result in services for male patients arebeing less accessible,  
and thus ccontributinge to worse outcomes.  This highlights the need for enhanced case-identification, 
research and services for male eating disorder patients to improve outcomes (21). We also found that 
mortality risk was higher amongst younger individuals within the cohort and individuals living in the 
lowest income neighbourhoods, highlighting issues around potential accessrelated to equity of access 
and quality of care; this warrants further investigation.
While there have been two meta-analyses estimating ED-related mortality, (5, 8) the existing 
literature has methodological issues including a lack of population-based surveillance data (limited to 
sub-regional studies and registries from restricted clinical practices(3, 22)), selection of study 
population, identification of cases, and small sample size.(9, 10, 17, 23-25) 





Finally, our results demonstrate the degree to which patients with EDs also experience 
important medical conditions and co-morbidities, such as congestive heart failure, diabetes, COPD and 
hypertension amongst others. Mechanisms through which EDs may have a causal impact on diverse 
chronic diseases have been described elsewhere. (4)
STRENGTHS AND LIMITATIONS
A major strength of our study was the use of a population-based sample, which is more 
representative and generalizable than cohorts based on a sample of hospitalised patients from 
individual treatment centres or insurance programs. An additional methodological strength was the 
use of the recommended SMR method, which is replicable and well established, to report excess 
mortality relative to the underlying population as well as controlling for sex and age through 
standardization (as opposed to merely reporting case-fatality rates within the clinical cohort).
One major limitation is the lack of validation of our algorithm for case-detection, which relied 
on hospital contact data and not outpatient contact data.  This may bias towards higher severity of 
cases and may also truncate the time between illness identification and mortality, which could result in 
an overestimation of mortality rates.(26) These are limitations of all research involving clinical cohorts 
based on administrative or insured services data.  These inherent limitations of the best data available 
underscore how important it is to have disease registries for eating disorders established 
internationally, with high quality clinical measures, which are available only in localized clinical 
research cohorts (22).  Moreover, the lack of data on ethnicity did not allow us to produce ethnic-
specific SMRs; future research should seek to address this limitation. Finally, this study included a 
specific group of ED diagnoses (anorexia nervosa, bulimia nervosa, and ED NOS) for which treatment is 





available in Ontario’s publicly funded system. We did not include other eating disorder diagnoses such 
as binge-eating disorder, and it is unclear whether the findings from our study would generalize to a 
broader array of eating disorder diagnoses.
IMPACT AND RELEVANCE
In summary, our study provides evidence of the high mortality rate associated with eating 
disorder diagnoses.  Furthermore, males with eating disorders have a higher risk of mortality than 
females, which underscores the importance of detecting and treating eating disorders in males even 
though they are relatively low in prevalence.  These findings are consistent with previous research on 
excess mortality; we effectively show the marked gender differences in risk of mortality and actual 
excess mortality in the eating disorder population.  Historically, the burden including mortality, of 
eating disorders, including mortality, has been documented to a lesser extent compared to studies of 
other psychiatric conditions despite its prevalence and high mortality rate. 
This study serves to highlight the need for ongoing population-based surveillance of eating 
disorder burden. Early intervention in eating disorders is known to be effective (27) (28) and presents 
an opportunity to reduce the mortality impact (high and early onset mortality) of these conditions. The 
inclusion of eating disorders amongst other disorders identified as high priority for improved 
surveillance and burden of disease data in mental health also highlights a need for better detection of 
and treatment of eating disorders and associated psychiatric comorbidities to improve long-term 
outcomes.  
Acknowledgements and Funding





This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry 
of Health and Long-Term Care (MOHLTC).  This study also received funding from the Labatt Family 
Innovation Fund in Brain Health (University of Toronto Department of Psychiatry) and the Medical 
Psychiatry Alliance, a collaborative health partnership of the University of Toronto, the Centre for 
Addiction and Mental Health, the Hospital for Sick Children, Trillium Health Partners, the MOHLTC and 
an anonymous donor. The opinions, results, views and conclusions reported in this paper are 
independent of the funding sources. Parts of this material are based on data and/or information 
compiled and provided by the Canadian Institute for Health Information (CIHI). The analyses, results, 
conclusions, opinions, views and statements expressed in the material are those of the authors, and 
not necessarily those of CIHI. Parts of this report are based on Ontario Registrar General (ORG) 
information on deaths, the original source of which is Service Ontario. The views expressed therein do 
not necessarily reflect those of ORG or the Ministry of Government Services.
No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.  
Author Contribution
PC, PK, SJB, CDO, TI, and KT all contributed to the formulation of the research question and 
study design. PK, SJB, CDO, and TI oversaw the data analysis, TI analyzed the data at ICES. SJB and TI 
drafted the manuscript. All authors contributed to review of the manuscript and approve of the final 
submission. 
Data Availability
The dataset from this study is held securely in coded form at ICES. While data sharing 
agreements prohibit ICES from making the dataset publicly available, access may be granted to those 





who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS. The full 
dataset creation plan and underlying analytic code are available upon request, understanding that the 
computer programs may rely upon coding templates or macros that are unique to ICES and are 
therefore either inaccessible or may require modification.
Declaration of Interest: None






1. de Oliveira C, Colton P, Cheng J, Olmsted M, Kurdyak P. The direct health care costs of eating disorders 
among hospitalized patients: A population-based study. International Journal of Eating Disorders. 2017; 50(12): 
1385-93.
2. Hudson JI, Hiripi E, Pope HG, Kessler RC. The Prevalence and Correlates of Eating Disorders in the 
National Comorbidity Survey Replication. Biological Psychiatry. 2007; 61(3): 348-58.
3. Fichter MM, Quadflieg N. Mortality in eating disorders - results of a large prospective clinical 
longitudinal study. International Journal of Eating Disorders. 2016; 49(4): 391-401.
4. E Mitchell J, Scott Crow. Medical complications of anorexia nervosa and bulimia nervosa. Current 
Opinion in Psychiatry. 2006; 19(4): 438-43.
5. Arcelus; J, Mitchell; AJ, Wales; J, Niels n S. Mortality Rates in Patients With Anorexia Nervosa and Other 
Eating Disorders: A Meta-analysis of 36 Studies. Archives of General Psychiatry. 2011; 68(7): 724-31.
6. Udo T, Grilo CM. Prevalence and Correlates of DSM-5–Defined Eating Disorders in a Nationally 
Representative Sample of U.S. Adults. Biological Psychiatry. 2018; 84(5): 345-54.
7. Smink FRE, van Hoeken D, Donker GA, Susser ES, Oldehinkel AJ, Hoek HW. Three decades of eating 
disorders in Dutch primary care: decreasing incidence of bulimia nervosa but not of anorexia nervosa. 
Psychological Medicine. 2015; 46(6): 1189-96.
8. Keshaviah A, Edkins K, Hastings ER, Krishna M, Franko DL, Herzog DB, et al. Re-examining premature 
mortality in anorexia nervosa: a meta-analysis redux. Compr Psychiatry. 2014; 55(8): 1773-84.
9. Smink FRE, van Hoeken D, Hoek HW. Epidemiology of Eating Disorders: Incidence, Prevalence and 
Mortality Rates. Current Psychiatry Reports. 2012; 14(4): 406-14.
10. Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB. Predictors of Mortality in Eating 
Disorders. JAMA Psychiatry. 2003; 60(2): 179-83.





11. Simon J, Schmidt U, Pilling S. The health service use and cost of eating disorders. Psychological Medicine. 
2005; 35(11): 1543-51.
12. Striegel-Moore RH. Health services research in anorexia nervosa. International Journal of Eating 
Disorders. 2005; 37 Suppl: S31-4; discussion S41-2.
13. C. Davies SJ, Tomisin Iwajomo, Oliveira Claire D, Judith Versloot, J. Reid R, Paul Kurdyak. The impact of 
psychiatric and medical comorbidity on the risk of mortality: a population-based analysis. Psychological 
Medicine. 2019: 1-9.
14. Kurdyak P, de Oliveira C, Iwajomo T, Bondy S, Trottier K, Colton P. Identifying Individuals with Eating 
Disorders Using Health Administrative Data. Canadian journal of psychiatry Revue canadienne de psychiatrie. 
2019: 706743719844183.
15. Breslow N, Day N. Statistical Methods in Cancer Research. Volume II. The Design and Analysis of Cohort 
Studies. International Agency for Research on Cancer, 1987.
16. Canada S. Health Indicators 2008. Statistics Canada, 2008.
17. Kask J, Ramklint M, Kolia N, Panagiotakos D, Ekbom A, Ekselius L, et al. Anorexia nervosa in males: excess 
mortality and psychiatric co-morbidity in 609 Swedish in-patients. Psychological Medicine. 2017; 47(8): 1489-99.
18. Møller-Madsen S, Nystrup J, Nielsen S. Mortality in anorexia nervosa in Denmark during the period 
1970-1987. Acta Psychiatrica Scandinavica. 1996; 94(6): 454-9.
19. Mond J, Mitchison D, Hay P. Eating disordered behavior in men: Prevalence, impairment in quality of 
life, and implications for prevention and health promotion. In: Current findings on males with eating disorders: 
195-215. Routledge/Taylor & Francis Group, 2014.
20. Murray SB, Nagata JM, Griffiths S, Calzo JP, Brown TA, Mitchison D, et al. The enigma of male eating 
disorders: A critical review and synthesis. Clinical Psychology Review. 2017; 57(Complete): 1-11.
21. Strother E, Lemberg R, Stanford SC, Turberville D. Eating Disorders in Men: Underdiagnosed, 
Undertreated, and Misunderstood. Eating Disorders. 2012; 20(5): 346-55.





22. Pinhas L, Morris A, Crosby RD, Katzman DK. Incidence and age-specific presentation of restrictive eating 
disorders in children: a Canadian Paediatric Surveillance Program study. Archives of Pediatrics & Adolescent 
Medicine. 2011; 165(10): 895-9.
23. Hart LM, Mitchison D, Hay PJ. The case for a national survey of eating disorders in Australia. Journal of 
eating disorders. 2018; 6: 30.
24. Austin SB, Hutcheson R, Wickramatilake-Templeman S, Velasquez K. The Second Wave of Public Policy 
Advocacy for Eating Disorders: Charting the Course to Maximize Population Impact. The Psychiatric clinics of 
North America. 2019; 42(2): 319-36.
25. Keski-Rahkonen A, Mustelin L. Epidemiology of eating disorders in Europe: prevalence, incidence, 
comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry. 2016; 29(6): 340-5.
26. Swanson SA, Field AE. Commentary: Considerations for the use of registry data to study adolescent 
eating disorders. International Journal of Epidemiology. 2016; 45(2): 488-90.
27. Arcelus J, Bouman WP, Morgan JF. Treating young people with eating disorders: transition from child 
mental health to specialist adult eating disorder services. European Eating Disorders Review: The Professional 
Journal of the Eating Disorders Association. 2008; 16(1): 30-6.
28. Currin L, Schmidt U. A critical analysis of the utility of an early intervention approach in the eating 
disorders. Journal of Mental Health. 2005; 14(6): 611-24.






Table 1: Demographic and Clinical Characteristics of the Eating Disorder cohort
VARIABLE Female Male TOTAL P-VALUE
Sex differences 
(unadjusted)
N=17,108 N=1,933 N=19,041  
Age at first diagnosis, Mean ± SD 25.76 ± 15.44 37.37 ± 23.91 26.94 ± 16.87 <0.001
N (% of 
cohort, 
females)
N (% of 
cohort, 
males)
N (% of cohort)
Age group at diagnosis
10_13 1,359 (7.9) 197 (10.2) 1,556 (8.2)
14_17 5,613 (32.8) 370 (19.1) 5,983 (31.4)  
18_24 4,015 (23.5) 279 (14.4) 4,294 (22.6)  
25_44 4,231 (24.7) 443 (22.9) 4,674 (24.5)  
45_64 1,201 (7.0) 279 (14.4) 1,480 (7.8)  
65_84 519 (3.0) 290 (15.0) 809 (4.2)  
>=85 170 (1.0) 75 (3.9) 245 (1.3)  
Neighbourhood Income Quintile
1 (low) 3,164 (18.5) 434 (22.5) 3,598 (18.9) <0.001
2 (medium-low) 3,149 (18.4) 366 (18.9) 3,515 (18.5)  
3 (medium) 3,143 (18.4) 365 (18.9) 3,508 (18.4)  
4 (medium-high) 3,460 (20.2) 377 (19.5) 3,837 (20.2)  
5 (high) 4,105 (24.0) 374 (19.3) 4,479 (23.5)  
Missing 87 (0.5) 17 (0.9) 104 (0.5)  
Rural residence
No 15,186 (88.8) 1,710 (88.5) 16,896 (88.7) 0.691
Yes 1,922 (11.2) 223 (11.5) 2,145 (11.3)  
Clinical Characteristics
Eating Disorder Diagnosis at 
cohort entry
AN and BN 121 (0.7) 7 (0.4) 128 (0.7) <0.001
AN and EDNOS * * 55 (*)  
AN only 5,437 (31.8) 398 (20.6) 5,835 (30.6)  
AN, BN, and EDNOS 291 (1.7) 7 (0.4) 298 (1.6)  
BN and EDNOS 2,981 (17.4) 353 (18.3) 3,334 (17.5)  
BN only 2,218 (13.0) 137 (7.1) 2,355 (12.4)  
EDNOS only 6,008 (35.1) 1,028 (53.2) 7,036 (37.0)  
Co-morbidity
Asthma 4,759 (27.8) 480 (24.8) 5,239 (27.5) 0.005
Cancer 638 (3.7) 225 (11.6) 863 (4.5) <0.001
COPD 1,237 (7.2) 300 (15.5) 1,537 (8.1) <0.001





Congestive Heart Failure 472 (2.8) 190 (9.8) 662 (3.5) <0.001
Diabetes 1,390 (8.1) 343 (17.7) 1,733 (9.1) <0.001
HIV 23 (0.1) 22 (1.1) 45 (0.2) <0.001
Legend: SD-standard deviation; AN-Anorexia Nervosa; BN-Bulimia Nervosa; EDNOS-Eating Disorder Not Otherwise 
Specified; COPD- Chronic Obstructive Pulmonary Disease; HIV, Human Immuno-Deficiency Virus


















Both Sexes      
Overall 155,921.03 1672 330.85 10.88 5.1 (4.8-5.3)
15-19 22,842.62 32 6.72 1.42 4.8 (3.3-6.7)
20-24 29,121.61 59 11.57 2.04 5.1 (4.0-6.6)
25-29 25,621.18 68 10.22 2.66 6.7 (5.3-8.4)
30-34 20,068.30 84 12.04 4.19 7.0 (5.6-8.6)
35-39 14,937.13 92 10.46 6.16 8.8 (7.2-10.8)
40-44 11,810.93 107 12.99 9.06 8.2 (6.8-10.0)
45-49 9,362.66 126 16.85 13.46 7.5 (6.3-8.9)
50-54 6,407.25 116 19.86 18.10 5.8 (4.9-7.0)
55-59 3,871.77 90 18.58 23.25 4.8 (3.9-6.0)
60-64 2,232.77 83 16.3 37.17 5.1 (4.1-6.3)
65-69 1,331.44 105 15.44 78.86 6.8 (5.6-8.2)
70-74 1,012.38 113 18.53 111.62 6.1 (5.1-7.3)
75-79 875.12 137 26.78 156.55 5.1 (4.3-6.1)
80-84 765.24 180 40.25 235.22 4.5 (3.9-5.2)
85-89 474.79 172 42.87 362.26 4.0 (3.5-4.7)
90+ 292.76 104 51.06 355.24 2.0 (1.7-2.5)
Female      
Overall 142,655.30 1249 272.29 8.83 4.6 (4.3-4.9)
15-19 20980.86 25 6.21 1.20 4.0 (2.7-6.0)
20-24 27195.17 50 10.83 1.85 4.6 (3.5-6.1)
25-29 24203.29 61 9.66 2.53 6.3 (4.9-8.1)
30-34 18855.12 71 11.31 3.77 6.3 (5.0-7.9)
35-39 13822.51 80 9.68 5.79 8.3 (6.6-10.3)
40-44 10747.7 90 11.82 8.37 7.6 (6.2 -9.4)
45-49 8479.574 106 15.26 12.50 7.0 (5.7-8.4)
50-54 5761.355 94 17.86 16.32 5.3 (4.3-6.4)
55-59 3433.343 73 16.48 21.26 4.4 (3.5-5.6)
60-64 1861.803 61 13.59 32.76 4.5 (3.5-5.8)
65-69 1048.189 70 12.16 66.78 5.8 (4.6-7.3)
70-74 755.4538 67 13.82 88.69 4.9 (3.8-6.2)
75-79 653.2047 85 19.99 130.13 4.3 (3.4-5.3)
80-84 583.2382 114 30.68 195.46 3.7 (3.1-4.5)
85-89 348.6016 119 31.48 341.36 3.8 (3.2-4.5)
90+ 236.0726 80 41.17 338.88 1.9 (1.6-2.4)
Male      





Overall 1,213.18 423 58.56 34.56 7.2 (6.6-8.0)
15-19  1861.75 7 0.5 4.17 13.9 (6.6-29.2)
20-24  1926.44 9 0.74 4.85 12.1 (6.3-23.3)
25-29  1417.89 7 0.56 5.00 12.5 (6.0-26.2)
30-34 1213.182 13 0.73 10.72 17.9 (10.4-30.8)
35-39 1114.625 12 0.78 10.77 15.4 (8.7-27.1)
40-44 1063.231 17 1.17 15.99 14.5 (9.0-23.4)
45-49 883.0904 20 1.59 22.65 12.6 (8.1-19.5)
50-54 645.8871 22 2 34.06 11.0 (7.2-16.7)
55-59 438.4278 17 2.1 38.77 8.1 (5.0-13.0)
60-64 370.974 22 2.71 59.30 8.1 (5.4-12.3)
65-69 283.245 35 3.29 123.57 10.7 (7.7-14.8)
70-74 256.9281 46 4.7 179.04 9.8 (7.3-13.1)
75-79 221.9124 52 6.79 234.33 7.7 (5.8-10.1)
80-84 182.0007 66 9.57 362.64 6.9 (5.4-8.8)
85-89 126.1937 53 11.4 419.99 4.7 (3.6-6.1)
90+ 56.68994 24 9.89 423.36 2.4 (1.6-3.6)
*SMRs are stratified by age-group where age is a time-dependent covariate reflecting age attained during follow-up as 
opposed to at baseline.  Time-dependent age calculated using STATA command STSPLIT.
Legend: SMR - standardized mortality ratio; CI – confidence interval























Age** 10 to 44- N=16,507
Age** (integer, continuous) 1.07 (1.06 – 1.07) 1.05 (1.05 – 1.06) < 0.001 (1)
Calendar year (integer, continuous) 0.90 (0.89 – 0.90) 0.91 (0.91 – 0.92) < 0.001 (1)
Sex (male versus female) 2.06 (1.92 – 2.21) 1.91 (1.78 – 2.05) < 0.001 (1)
Neighbourhood income quintile
    1 (low)
    2 (medium-low)
    3 (medium)
    4 (medium-high)























Rural residence (versus urban residence) 0.65 (0.60 – 0.71) 0.69 (0.63 - 0.75) < 0.001 (1)
Medical co-morbidity indicators (binary):
   Congestive heart failure 2.45 (2.23 – 2.69) < 0.001 (1)
   COPD      1.07 (0.99 – 1.14) 0.07 (1)
   Cancer 2.43 (2.25 – 2.62) < 0.001 (1)
   Asthma 1.01 (0.96 – 1.06) 0.76 (1)
   Diabetes 1.75 (1.65 – 1.86) < 0.001 (1)
   HIV 2.16 (1.75 – 2.67) < 0.001 (1)
Age** 45 and older- N=2532
Age** (integer, continuous) 1.08 (1.08 – 1.08) 1.07 (1.07 – 1.08) < 0.001 (1)
Calendar year (integer, continuous) 0.88 (0.87 – 0.88) 0.89 (0.88 – 0.89) < 0.001 (1)
Sex (male versus female) 1.92 (1.82 – 2.01) 1.91 (1.82 – 2.02) < 0.001 (1)
Neighbourhood income quintile:
    1 (low)
    2 (medium-low)
    3 (medium)
    4 (medium-high)























Rural residence (versus urban residence) 1.27 (1.19 – 1.35) 1.22 (1.15 – 1.30) < 0.001 (1)
Medical co-morbidity indicators (binary):
   Congestive heart failure 1.32 (1.25 – 1.38) < 0.001 (1)
   COPD 1.06 (1.01 – 1.11) < 0.03 (1)
   Cancer 2.24 (2.14 – 2.35) < 0.001 (1)
   Asthma 0.94 (0.89 – 0.99) 0.03 (1)
   Diabetes 0.89 (0.86 – 0.94) < 0.001 (1)
   HIV 2.06 (1.59 – 2.66) < 0.001 (1)
* Likelihood ratio test for removal of covariate from fully adjusted model shown.  
** Age is defined as time-dependent covariate, meaning age of cohort member attained over follow-up and not at baseline. 
Time-dependent age is calculated using STATA command STSPLIT. 
Legend: COPD- Chronic Obstructive Pulmonary Disease; HIV, Human Immuno-Deficiency Virus





Appendix Table 1: Age-Sex matched person years of life lost and 95% CI in ED cohort and Ontario population in 
2011
ED Cohort Ontario Population Excess PYLL (%)
PYLL (95% CI) PYLL (95% CI)
Both 
Sexes 191.5 (189.3-193.7) 29.6 (28.8-30.5) 85%
Male 375.4 (364.4-386.6) 29.6 (28.7-30.5) 92%
Female 174.8 (172.6-177.0) 29.7 (26.6-32.7) 83%
Legend: ED – eating disorders; CI – confidence interval; PYLL – Person Years of Life Lost





Figure 1: Standardized mortality ratios-by sex and age-group, all-cause mortality rates observed within the eating disorders cohort (1991-2013) 
and Ontario (2011) mortality rates
Y1 axis label (left) Standardized Mortality Ratio (SMR)
Y2 axis label (right) Observed morality rate (per 1000 person years)
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